Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report

[1]  A. Plessier,et al.  Budd-Chiari Syndrome , 2008, La Revue de medecine interne.

[2]  F. Rosendaal,et al.  Etiology, management, and outcome of the Budd-Chiari syndrome. , 2009, Annals of internal medicine.

[3]  D. Valla.  Primary Budd-Chiari syndrome. , 2009, Journal of hepatology.

[4]  J. Horton,et al.  Budd–Chiari syndrome: illustrated review of current management , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[5]  P. Kamath,et al.  Erratum: Model for end-state liver disease (MELD) exception for Budd-Chiari syndrome (Liver Transplantation (2006) vol. 12 (S93-94)) , 2007 .

[6]  P. Kamath,et al.  Model for end‐stage liver disease (MELD) exception for Budd‐Chiari syndrome , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  S. Uemoto,et al.  Surgical Techniques and Long‐Term Outcomes of Living Donor Liver Transplantation for Budd‐Chiari Syndrome , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  H. Yoshiji,et al.  Successful treatment of acute Budd-Chiari syndrome with percutaneous transluminal angioplasty , 2004, Abdominal Imaging.

[9]  D. Valla.  The diagnosis and management of the Budd‐Chiari syndrome: Consensus and controversies , 2003, Hepatology.

[10]  S. Shrestha,et al.  Bacterial peritonitis in hepatic inferior vena cava disease: a hypothesis to explain the cause of infection in high protein ascites. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  H. Iwata,et al.  Epidemiological and clinical features of Budd-Chiari syndrome in Japan. , 1995, Journal of hepatology.